Dhillon Punit

Avg. Two Year Performance

(79%) Avg. Purchase Return
(34%) Compound
85% Avg. Sale Return
36% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(22%)(47%)(41%)(68%)(79%)
Purchase Success Rate0 of 20 of 20 of 20 of 20 of 2
Average Sale Return7%(3%)52%81%85%
Sale Success Rate1 of 10 of 11 of 11 of 11 of 1

Skye Bioscience, Inc.

Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 339.17K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Inovio Biomedical Corp.

Health Services » Medical Instruments & Supplies

VP, Finance & Operations:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Oncosec Medical Inc

Drugs » Biotechnology

Director:

Holdings: 485.26K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Arch Therapeutics, Inc.

Health Services » Medical Appliances & Equipment

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--